Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Universite Paris Descartes patents (2015 archive)


Recent patent applications related to Universite Paris Descartes. Universite Paris Descartes is listed as an Agent/Assignee. Note: Universite Paris Descartes may have other listings under different names/spellings. We're not affiliated with Universite Paris Descartes, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "U" | Universite Paris Descartes-related inventors


10/22/15 / #20150299798

Method for classification of liver samples and diagnosis of focal nodule dysplasia, hepatocellular adenoma, and hepatocellular carcinoma

The present invention relates to the technical field of liver diseases, their classification and diagnosis. It provides a new method for classifying a liver sample between non-hepatocellular sample; hepatocellular carcinoma (hcc) sample with further classification into one of subgroups g1 to g6; focal nodule dysplasia (fnh) sample; hepatocellular adenoma (hca) sample with further classification into hnf1a mutated hca, inflammatory hca, β catenin mutated hca or other hca sample; and other benign liver sample, based on determination in vitro of genes expression profiles and analysis of the expression profile using algorithms calibrated with reference samples. ... Universite Paris Descartes

09/24/15 / #20150268245

In vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method

The present invention relates to the prognosis of the outcome of a cancer in a patient, which prognosis is based on the quantification of one or several biological markers that are indicative of the presence of, or alternatively the level of, the adaptive immune response of said patient against said cancer.. . ... Universite Paris Descartes

09/17/15 / #20150258127

Methods for preventing antiphospholipid syndrome (aps)

The present invention relates to the prevention or treatment of antiphospholipid syndrome (aps) in a patient in need thereof (e.g. Patients affected with primary aps, a secondary aps, a catastrophic aps (caps) or a transplant recipient with antiphospholipid antibodies (apa)). ... Universite Paris Descartes

04/23/15 / #20150110806

Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia

The present invention concerns the use of an inhibitor of an interaction between type iv pilus-associated protein and cd147 for preventing or treating meningoccal bacteraemia and/or infection. The present invention also relates to the combined use of such inhibitor and of an anti-bacterial compound, such as one used to prevent or treat a meningococcal infection. ... Universite Paris Descartes

04/16/15 / #20150105426

Topical emulsions based on mixtures of local eutectic anaesthetics and fatty acids as analgesics, antalgics, or as sexual retardants

The invention relates to novel formulations for topical local anaesthesia and for the use thereof as analgesics, antalgics, or as sexual retardants.. . ... Universite Paris Descartes

04/16/15 / #20150104463

Methods and kits for predicting the risk of having a cardiovascular event in a subject

The present invention relates to in vitro methods and kits for predicting the risk of having a cardiovascular event in a subject. More particularly, the invention relates to an in vitro method for predicting the risk of a cardiovascular event in a subject, said method comprising the step of measuring the level of il-17 in a blood sample obtained from said subject.. ... Universite Paris Descartes

03/19/15 / #20150076333

Microscope for high spatial resolution imaging a structure of interest in a sample

A microscope for high spatial resolution imaging a structure of interest in a sample comprising a substance having a first state with first spectral properties and a second state with second spectral properties, the microscope comprising: an objective-lens assembly, a wave front modulating optical device adapted to spatially vary an intensity of a transfer light beam, a probe detector arranged to detect an optical measurement signal from a portion of the substance in the second state and placed in an area of the transfer light beam with an intensity adapted not to transfer the substance between the first and second states said microscope comprising a phase contrast microscopy system which includes an intensity detector arranged to detect an intensity of an illuminating light beam after said illuminating light beam has passed through the sample, the objective-lens assembly and the wave front modulating optical device.. . ... Universite Paris Descartes

03/12/15 / #20150073034

Methods and pharmaceutical compositions for the treatment of hypertension

The present invention relates to an inhibitor of neutrophil gelatinase-associated lipocalin (ngal) activity or expression for use in a method for treating or preventing hypertension in a subject in need thereof.. . ... Universite Paris Descartes

03/05/15 / #20150064455

Materials coated with calixarenes

This invention relates to the direct grafting of a calixarene mostly onto the surface of a material, as well as to a grafting process, and certain calixarene intermediates useful for carrying the grafting process.. . ... Universite Paris Descartes

02/26/15 / #20150057332

Methods for the treatment of nonalcoholic steatohepatitis

The present invention relates to the treatment of nonalcoholic steatohepatitis (nash), in particular to a compound that inhibits mir-21 expression for use in the treatment of nonalcoholic steatohepatitis.. . ... Universite Paris Descartes

02/19/15 / #20150050681

Method for measuring calcineurin activity

The present invention relates to a method for measuring the activity of calcineurin in a biological sample wherein a kinase inhibitor is present in the assay reaction mix.. . ... Universite Paris Descartes

02/19/15 / #20150050290

Method and pharmaceutical composition for use in the treatment or the prevention of aneurysm

The present invention relates to a compound which is an antagonist of il-1 beta or an inhibitor of il-1 beta expression for use in the treatment or the prevention of aneurysm. In another embodiment, the invention relates to a pharmaceutical composition for use in the treatment or the prevention of aneurysm comprising an antagonist of il-1 beta or an inhibitor of il-1 beta expression.. ... Universite Paris Descartes

02/19/15 / #20150050282

Glycoconjugates and use thereof as vaccine against shigella flexneri serotype 3a and x

The present invention relates to compounds derived from sugars which reproduce the epitopes of shigella flexneri serotypes 3a and x and to the use thereof for the preparation of vaccine compositions. More specifically, the subject matter of the present invention relates to novel glycoconjugated compounds comprising oligosaccharides or polysaccharides described hereinafter, to the method for synthesizing these oligosaccharides or polysaccharides and glycoconjugates, to derivatives of these oligosaccharides or polysaccharides, to compositions containing same, and also to the use of the glycoconjugates for vaccination purposes. ... Universite Paris Descartes








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Universite Paris Descartes in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Universite Paris Descartes with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###